We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NAM
126
NorthCoast Asset Management
Connecticut
$2.25M +$2.42M +47,530 New
GCC
127
Guardian Capital (Canada)
Ontario, Canada
$2.22M +$2.39M +46,965 New
OA
128
Oak Associates
Ohio
$2.07M +$2.23M +43,800 New
BF
129
BOK Financial
Oklahoma
$2M +$2.15M +42,300 New
RCM
130
Riverhead Capital Management
Delaware
$1.99M +$2.14M +42,000 New
OC
131
Oppenheimer & Co
New York
$1.97M +$2.12M +41,722 New
CIBC World Market
132
CIBC World Market
Ontario, Canada
$1.97M +$2.12M +41,697 New
Fifth Third Bancorp
133
Fifth Third Bancorp
Ohio
$1.87M +$2.01M +39,520 New
ACM
134
Aviance Capital Management
Florida
$1.83M +$1.97M +38,595 New
ACM
135
Ativo Capital Management
Illinois
$1.74M +$1.88M +36,865 New
Barclays
136
Barclays
United Kingdom
$1.73M +$1.86M +36,481 New
Commonwealth Equity Services
137
Commonwealth Equity Services
Massachusetts
$1.7M +$1.83M +35,994 New
B
138
Bailard
California
$1.7M +$1.83M +36,002 New
CAM
139
Capstone Asset Management
Texas
$1.68M +$1.81M +35,506 New
TG
140
TCW Group
California
$1.67M +$1.79M +35,200 New
Geode Capital Management
141
Geode Capital Management
Massachusetts
$1.66M +$1.78M +35,021 New
GGPS
142
Gary Goldberg Planning Services
New York
$1.61M +$1.73M +34,000 New
B
143
Baird
Wisconsin
$1.6M +$1.72M +33,757 New
QIM
144
Quantitative Investment Management
Virginia
$1.59M +$1.72M +33,700 New
FBT
145
First Bankers Trust
Kentucky
$1.51M +$1.63M +31,956 New
TGI
146
Tradewinds Global Investors
California
$1.42M +$1.53M +30,022 New
RC
147
RegentAtlantic Capital
New Jersey
$1.35M +$1.46M +28,615 New
HI
148
HBK Investments
Texas
$1.35M +$1.45M +28,500 New
William Blair & Company
149
William Blair & Company
Illinois
$1.35M +$1.45M +28,491 New
SFM
150
Systematic Financial Management
New Jersey
$1.24M +$1.34M +26,300 New
4 5
6
7 8

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.